TO THE EDITOR
l-Asparaginase from Escherichia coli, which catalyzes the hydrolysis of l-asparagine to l-asparatic acid and ammonia, has been used as an effective therapeutic agent for the treatment of acute lymphoblastic leukemia and lymphosarcoma. 1, 2 However, only limited types of leukemia cells are sensitive to l-asparaginase treatment. Murine leukemia cells treated with l-asparaginase undergo apoptosis, 3 which is closely associated with the cell cycle arrest in G1 phase. 4 Apoptosis of leukemia cells is also induced by lacking l-asparagine from the culture medium. 4 Apoptosis is closely associated with the activation of caspases, mitochondrial permeability transition, cell volume loss, chromatin condensation and nucleosomal DNA fragmentation. [5] [6] [7] [8] The present study deals with the fragmentation of chromosomal DNA and activation of caspase-3 (CPP32, Yama or apopain) in murine and human leukemia cells treated with amino acid-deficient medium.
First, we examined the fragmentation of chromosomal DNA in murine leukemia cells (L5178Y and L1210) induced by treatment with one amino acid-deficient medium out of total 20 amino acids in the RPMI 1640 medium containing 10% dialyzed fetal bovine serum, penicillin (50 U/ml) and streptomycin (50 g/ml) for 24 h. Among them, valine-and isoleucine-deficient media induced the fragmentation of chromosomal DNA within 24 h incubation. Then, DNA fragmentation and caspase-3 activity of murine leukemia cells (L5178Y and L1210) treated with one of the amino acid-deficient media (lvaline, l-isoleucine and l-asparagine) was tested ( Figure 1 ). The treatment of L5178Y or L1210 cells with valine-deficient medium for 8, 12, 16, 20 and 24 h causes the fragmentation of chromosomal DNA into the size equivalent to single and multiple nucleosomes (Figure 1a) . A similar phenomenon is also observed for L5178Y and L1210 cells treated with isoleucine-deficient medium for 12, 16, 20 and 24 h incubation. DNA fragmentation was also observed in L5178Y cells treated with asparagine-deficient medium for 20 and 24 h incubation but was not observed in L1210 cells within 24 h incubation (data not shown). Figure 1b shows the caspase-3 activity of L5178Y and L1210 cells treated with one amino acid-deficient medium (valine, isoleucine or asparagine) during the course of incubation (0-24 h). In the case of L5178Y cells, the caspase-3 activity of valine-deficient medium increases with incubation time and becomes maximal for 12 h followed by decreasing activity (curve a). In the treatment with isoleucine-deficient medium, the activity appears at more than 12 h incubation and increases linearly with time (curve b). In asparaginedeficient medium, the caspase-3 activity was little observed (curve c). pase-3 activity of L1210 cells treated with valine, isoleucine and asparagine is shown by curves a, b and c, respectively. From the results obtained above, it can be concluded that DNA fragmentation of L5178Y or L1210 cells is closely associated with the enhancement of caspase-3 activity. In human leukemia cells (THP-1 and U937 cells), apoptosis was effectively induced by valine-deficient medium in comparison with other amino acid deficiency (isoleucine or asparagine).
Experiments are now in progress not only to clarify the mechanism of apoptosis induced by valine-deficient medium but also to apply to the therapy of human leukemia using valine-degrading enzyme. 7 The protease activity of caspase-3 was determined by the method of Enari et al.
